ARTICLE | Company News
KS Biomedix other research news
July 12, 1999 7:00 AM UTC
KSB said that it has developed a 70 percent human chimeric version of its SMA-6H9 sheep monoclonal antibody that binds the CEA antigen on colon cancer cells. KSB said the chimeric antibody retains hig...